Introduction
Behçet's disease (BD) is a refractory, systemic infl ammatory disease characterized by four main symptoms: oral aphthous ulcers, ocular lesions, skin lesions, and genital ulcers. It is occasionally responsible for infl ammation in tissue and organs throughout the body including the vascular system, central nervous system, gastrointestinal tract, lungs, kidneys, and joints [1] . The etiology of BD is unknown and BD is seen most frequently among Turkish, Israeli and Japanese populations. It has been claimed that immunologic abnormalities triggered by microbial agents or environmental factors in genetically susceptible individuals play an important role in the development of this disease [2] . Vascular injuries, hyperfunction of neutrophils, and autoimmune responses are also signifi cant characteristics of BD [3] , but the clinical features of BD differ from those of classic autoimmune diseases [4] . It has been shown that in BD endothelial damage could occur as a result of different immunological abnormalities [5] .
Angiotensin-converting enzyme (ACE) has been identifi ed as a membrane-bound enzyme in several types of cells, including vascular endothelial cells, various absorptive epithelial cells, neurons, macrophages, and T lymphocytes. It is also present in a circulating form, produced by vascular endothelial cells, in biological fl uids such as plasma. The levels of tissue and circulating ACE activities are under tight genetic control [6] . The ACE gene is located on chromosome 17 and shows polymorphism that is characterized by the presence of a 287-base pair alu repeat within intron 16 [7] . The presence of the extra fragment is associated with lower circulating and tissue ACE activity, and this variant of the ACE gene is termed the insertion (or I) allele. The absence of this fragment (deletion or D allele) is associated with relatively higher ACE activity [8] . The allelic frequency of the ACE gene varies among different racial and ethnic groups [9, 10] .
This study aimed to evaluate the possible role of the ACE I/D polymorphism in BD.
Subjects and Methods
Genomic DNA from 35 Turkish patients (23 male, 12 female), diagnosed with BD according to the International Study Group criteria, and 150 healthy individuals (97 male, 53 female) was prepared from peripheral blood samples by a standard phenol/chloroform extraction method [11] . Polymerase chain reaction (PCR) was used to detect the presence of I and D alleles in intron 16 of the ACE gene according to the method described by Rigat et al. [8] using an upstream primer 5 -CTGGAGACCACTCCCATCCTTTCT-3 and downstream primer 5 -GATGTGGCCATCACATTCGT-CAGAT-3 . Amplifi cation was performed for 35 cycles with denaturation, extension and annealing temperatures of 94, 60 and 72 ° C, respectively. Amplifi ed fragments (490 bp for the I allele and 190 bp for the D allele) were separated by 2% agarose gel electrophoresis and identifi ed using the UVI Gel Documentation system.
Conformity with the Hardy-Weinberg equilibrium for genotype distribution was estimated by 2 test. A value of p ! 0.05 was considered statistically signifi cant. All statistical analyses were carried out using the SPSS 10.0 computer program (Statistical Package for Social Sciences, SPSS Inc.).
Results
Electrophoretic identifi cation of the alleles according to their PCR product length is shown in fi gure 1 and genotype and allele frequencies are given in table 1 . In BD patients the D allele was seen in 59 alleles out of 70 chromosomes corresponding to an allele distribution of 84.3%, and the I allele in 11 chromosomes (15.7%). Differences in DD, ID and II genotypes did not show statistical signifi cance between the BD patients and controls. However, D and I allele frequencies showed sta- 2, 4, 5, 7, 8), ID (lanes 3, 9) , II (lanes 6), M (marker, 100-bp ladder). 
Discussion
BD is a systemic infl ammatory disorder with unknown pathogenesis. Although the most common features are recurrent oral and/or genital ulcerations, many other systems such as the gastrointestinal tract, the central nervous system, and the skin and blood vessels may be affected. The prevalence and incidence of the condition and its constituent manifestations show marked variability among different populations [12] . The vascular injuries are superimposed on a hypercoagulability that is also characteristic of BD and which may be due in part to activated endothelial cells and activated platelets [3] .
Extensive expression of adhesion molecules on vascular endothelial cells of BD patients was reported recently, suggesting that adhesion molecules might play an important role in vasculitis. In addition, plasma endothelin-1 (ET-1) concentrations were found to be signifi cantly increased in patients with active BD. Elevated ET-1 is the direct result of its increased synthesis from injured vascular endothelial cells. Plasma ET-1 levels correlate with disease activity. These fi ndings indicate that ET-1 may play an important role in the development or progression of vasculitis [5] .
ACE in mononuclear cells may participate in local production or degradation of regulatory peptides (for example, at the site of infl ammation reactions). Some naturally occurring infl ammatory peptides, such as bradykinin and substance P, are partially inactivated by ACE. The renin-angiotensin system (RAS) itself is likely to infl uence cytokine synthesis; interleukin-1-induced cytokine synthesis was increased by approximately 20% in the presence of angiotensin II. Like ACE, angiotensinogen gene expression is subject to tissue-specifi c hormonal and developmental controls. Endocrine RAS activities are associated with the regulation of vascular tonus and cardiac function in the body, while autocrine RAS activities contribute to infl ammation reactions in tissues [6] .
ACE is involved in the conversion of angiotensin I to angiotensin II through its metalloproteinase enzymatic activity and plays a major role in RAS and kallikrein-kininogen systems. Angiotensin II increases vascular smooth muscle cell contraction and affects smooth muscle proliferation, monocyte adhesion, and platelet adhesion and aggregation [13] .
ACE is attractive as a candidate to play a role in the development of vascular pathological states. Evidence suggests that the DD genotype increases susceptibility for coronary heart disease, myocardial infarction, and both diabetic and nondiabetic renal disease [14] . This enzyme plays an integral role in the regulatory system responsible for endothelial control and vascular tone, systems that are commonly affected in lupus patients [13] . In addition, it has been shown that the circulating level of the ACE is approximately twofold higher in individuals homozygous for the ACE deletion (D) allele [8] . An association of the D genotype with chronic infl ammation in the bronchiole in asthma has been indicated [6] . In tissues, the production of angiotensin I is higher than in plasma (80 vs. 20%). Recent studies have shown that control of RAS in tissues is independent of levels in circulation. ACE expression is closely regulated by dexamethasone, because glucocorticoid-responsive elements are located in the ACE promoter. These studies indicate multifactorial control of ACE expression in tissues [15] .
In this study we investigated the relationship between ACE polymorphism and BD. According to these preliminary observations, BD patients living in Denizli province of Turkey show a D allele frequency that is greater than that in the general population, representing a statistically signifi cant difference (
